Berberine inhibits intestinal carcinogenesis by suppressing intestinal pro-inflammatory genes and oncogenic factors through modulating gut microbiota

BACKGROUND: The role of Berberine (BBR) in colorectal cancer (CRC) and gut microbiota has begun to appreciate. However, there was no direct evidence confirm that the gut microbiota regulated by BBR could inhibit CRC. This report investigated the effect of stool from BBR treated subjects and its effe...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Haitao, Ye, Chenxiao, Cai, Biyu, Zhang, Fan, Wang, Xuanying, Zhang, Jin, Zhang, Zewei, Guo, Yong, Yao, Qinghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9123795/
https://www.ncbi.nlm.nih.gov/pubmed/35596224
http://dx.doi.org/10.1186/s12885-022-09635-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9123795/
https://www.ncbi.nlm.nih.gov/pubmed/35596224
http://dx.doi.org/10.1186/s12885-022-09635-9

Ejemplares similares